This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 18 and 60
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

The purpose of this study is to compare the test product Budesonide/formoterol Easyhaler with the marketed product Symbicort Turbuhaler in terms of the drug absorbed into the bloodstream.

Provided treatments

  • Drug: Charcoal and Budesonide/formoterol Easyhaler 320/9 microg
  • Drug: Charcoal and Symbicort Turbuhaler
  • Drug: Budesonide/formoterol Easyhaler 320/9 microg
  • Drug: Symbicort Turbuhaler forte

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01593826. The sponsor of the trial is Orion Corporation, Orion Pharma and it is looking for 72 volunteers for the current phase.
Official trial title:
Pharmacokinetic Study Comparing Two Budesonide/Formoterol Fumarate Dihydrate Device-metered Dry Powder Inhalers, Budesonide/Formoterol Easyhaler 320/9 Microg/Inhalation and Symbicort Turbuhaler Forte; a Randomised, Double-blind, Single Centre, Single Dose, Crossover Study in Healthy Subjects